placeholder placeholder placeholder
 

BREAKING NEWS:
Biolex Therapeutics Researchers Present Locteron® Phase 2a Hepatitis C Trial Results at EASL Conference

Biolex Announces Presentation of Preclinical Results for Clot Buster BLX-155 at SIR Annual Scientific Meeting

Biolex Announces Publication of Phase 1 Locteron® Results in the Journal of Interferon & Cytokine Research
search home sitemap contacts directions disclaimer privacy
©2004 Biolex, Inc. All rights reserved.